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Haematological 
Investigations in Children 
 
C Halsey, EA Chalmers 
 
 
The haematology laboratory is able to perform a number of tests to help establish the cause of illness 
in children. The full blood count (FBC, also known as a complete blood count, CBC) is one of the most 
basic blood tests performed on children attending hospital or a primary care clinic. All doctors should 
therefore have an understanding of how the test is performed, possible pitfalls, be able to interpret 
results and know when more specialised testing or advice is required. Other haematological 
investigations in routine use include coagulation screens, blood film examination, reticulocyte counts 
and methods for estimation of iron stores and detection of abnormal haemoglobins. This section will 
focus on these basic tests and simple algorithms for the subsequent investigation and differential 
diagnosis of the commonest haemato-logical abnormalities encountered in general paediatric practice. 
The reader is referred to Chapter 15 for an account of the clinical presentation and management of 
primary haematological disorders in children. 
Full Blood Count 
The FBC is a numerical estimate of the number of red cells, platelets and white cells in a given sample 
of blood along with measurement of the haemoglobin concentration and various red cell indices some 
of which are directly measured and others derived. Blood is collected into an anticoagulant solution 
(usually EDTA) and transported to the laboratory. Although counting of each component can be done 
manually it is now routine to use automated counters in almost all haematology laboratories. These 
counters recognise cells on the basis of size and physical characteristics. There are two main methods 
(often used in conjunction). Electrical impedance measurement is based on the fact that blood cells are 
very poor conductors of electricity. Therefore when cells in a conducting medium are made to flow in 
single file through an aperture across which an electric current flows, there is a measurable increase in 
electrical impedance which is proportional to the volume of the cell. In this way cells can be both 
counted and sized. The second method relies on characteristic patterns of light scatter and absorbance 
as cells pass through a laser beam, this is particularly useful for the recognition and counting of the 
different types of white blood cell (to produce a white cell differential count). In addition counters 
estimate haemoglobin by lysing the red blood cells and measuring the optical density of the resulting 
solution at an appropriate wavelength. A typical readout from an automated counter is shown in Fig. 
28.1. 
 
Key Learning Points 
• Automated blood counters identify cells on the basis of size and laser light scatter patterns. Haemoglobin 
concentration is measured by lysis of red blood cells and measuring the optical density of the resulting 
coloured solution 
• Because automated machines rely on size as one way to classify cells it is possible to get artefactual results 
in some situations. For example nucleated red blood cells are often counted as white cells and fragmented 
red cells are counted as platelets. Any unusual count should be checked manually with a blood film. 
Red Cell Indices 
In addition to the red cell count and haemoglobin concentration it is clinically useful to know the size 
of red cells (mean cell volume, MCV) the amount of haemoglobin per cell (mean cell haemoglobin, 
MCH) and a measure of the variation in size of individual red cells (red cell distribution width, RDW). 
Collectively these values are known as red cell indices. They are particularly useful in the assessment 
of likely causes of anaemia (see below). 
Blood Film 
Examination of a stained blood film is an essential part of the assessment of most haematological 
disorders. Many haematological diseases have characteristic changes. In some cases it is possible to 
diagnose a disorder purely from the blood film (e.g. hereditary elliptocytosis) in most cases other 
confirmatory tests are needed. The blood film may be very useful in identifying artefactual results 
such as thrombocytopenia caused by platelet clumping. Systemic disease may also produce blood film 
changes for example sepsis may be accompanied by an increase in immature neutrophils (left shift or 
band forms), toxic granulation and formation of Döhle bodies (pale blue cytoplasmic inclusions) 
within neutrophils. These latter changes are particularly useful in assessment of neonates. Figure 28.2 
shows some of the characteristic red cell changes seen on the blood film along with common causes for 
these appearances. 
Reticulocyte Count 
Reticulocytes are young red cells that have lost their nucleus but still contain substantial amounts of 
ribosomal RNA, leading to their characteristic bluish purple colour on standard haematoxylin and 
eosin (H&E) staining of blood films. They can be more easily identified using special stains such as 
new methylene blue and can be counted manually or on some automated counters. They can be 
expressed as a percentage of the total red cells or an absolute count. Reticulocyte numbers are very 
useful in the evaluation of anaemia as they allow a distinction to be made between inadequate marrow 
production of red cells (associated with a low reticulocyte count) and excessive destruction or loss of 
red cells in the periphery (usually associated with increased reticulocyte release from the marrow). 
Normal Ranges 
The synthesis of blood cells and coagulation proteins go through various changes during development 
(discussed further in Chapter 15). This is particularly marked in the neonatal period and early infancy 
because of adaptive changes needed for the transition between the uterine microenvironment and the 
outside world. Therefore when interpreting any haematological value it is important to be aware of 
age appropriate normal ranges. Table 28.1 gives approximate values for the FBC from birth to 
adulthood. Normal ranges should ideally be determined using the local population and the actual 
instruments in everyday use in the laboratory. In paediatrics it is difficult to obtain sufficient numbers 
of samples from healthy controls and therefore estimates are usually made using published normal 
ranges. 
Key Learning Points 
• Normal ranges vary with age, especially in infants. Always interpret results in light of age appropriate normal 
ranges.  
• Haemoglobin values are high at birth then fall to a nadir at around 3 months of age before slowly rising again, 
• Infants and children up to the age of 4 years have a relative lymphocytosis 
Investigation of a Low Haemoglobin in  
Infancy and Childhood 
Although there are a multitude of causes for anaemia in this age range the majority of causes can be 
ascertained by logical use of relatively few tests. An initial history should focus on the length and 
speed of onset of symptoms, a dietary history, ethnic origin, any other medical conditions and any 
family history of blood disorders. When considering the differential diagnosis for any haematological 
disorder it is useful to divide the causes into those due to underproduction of cells from the bone 
marrow, those due to peripheral destruction of cells and those due to loss of cells from the circulation 
(haemorrhage or sequestration). A simple way to narrow down the list of differential diagnoses for 
anaemia is to look at the red cell indices. There are a limited number of causes of a hypochromic 
microcytic anaemia or a macrocytic anaemia – the common causes are listed in Table 28.2. When 
assessing a normocytic anaemia a reticulocyte count is useful to distinguish between marrow 
production problems and peripheral destruction or haemorrhage. The blood film may also be useful 
with characteristic changes seen in some red cell haemoglobin or enzyme disorders (see Fig 28.2). 
 
Key Learning Points 
When formulating a differential diagnosis for low blood counts (red cells, white cells or platelets) always consider 
the following mechanisms: 
• Reduced production of cells 
 - Disorders interfering with normal haemopoiesis such as nutritional deficiency or aplastic anaemia  
 - Primary bone marrow failure syndromes 
 - Secondary marrow infiltration 
• Peripheral destruction of cells 
• Loss from the body (eg haemorrhage) or sequestration within the tissues or organs 
Hypochromic Microcytic Anaemia 
The main differential diagnosis is between iron deficiency anaemia and thalassaemia. Thalassaemia 
major presents in early infancy with a transfusion dependent anaemia and a characteristic blood film 
and electrophoretic findings (absent haemoglobin A) and usually presents little diagnostic difficulty. 
Thalassaemia trait does not produce significant anaemia alone but does give hypochromic microcytic 
indices often in association with a raised red cell count but relatively normal RDW. In contrast iron 
deficiency usually gives a low red cell count but a raised RDW (this being a measure of variation in 
red cell width and therefore raised in the presence of anisocytosis). The blood film is often helpful. 
Beta thalassaemia trait is characterised by basophilic stippling (see Fig 28.2). Alpha thalassaemia trait 
has few characteristic features. Iron deficiency gives marked anisopoikilocytosis with hypochromic 
red cell fragments, pencil and teardrop cells and frequent accompanying thrombocytosis.  
Tests to Diagnose Iron Deficiency 
Iron deficiency can be sub-divided into initial depletion of iron stores followed by iron deficient 
erythropoiesis and finally the development of anaemia (see Fig 28.3). Serum ferritin is the first marker 
of depleted iron stores in the body. It is diagnostic if low, but false negative results can be seen because 
ferritin is an acute phase reactant and therefore can be elevated with acute inflammation or infection 
even in the presence of iron deficiency. As iron deficiency progresses the transferrin (measured as total 
iron binding capacity—TIBC) becomes elevated with reduced serum iron. The ratio of these two 
results can be expressed as the transferrin saturation. Immediate precursors of haem accumulate (zinc 
(free erythrocyte) protoporphyrin). Finally a hypochromic microcytic anaemia develops. Other tests 
include measurement of soluble transferrin receptors (increased in iron deficiency). The gold standard 
test remains Perls’ staining of a particulate bone marrow biopsy specimen for iron but this is rarely 
necessary. 
Tests to Diagnose Thalassaemia 
In order to understand tests for thalassaemia properly it is necessary to be aware of the composition of 
haemoglobin and the developmental changes that occur in the use of various globin chains, these are 
discussed on page xx chapter 15. Diagnosis of thalassaemia is usually made by tests that separate the 
haemoglobin molecules on the basis of electrical charge; this allows quantitation of the normal 
haemoglobins HbA (α2β2), HbA2 (α2δ2) and HbF (α2γ2) and also detection of abnormal haemoglobins 
that contain amino acid changes that alter charge (such as sickle cell HbS). The two main methods in 
use are haemoglobin electrophoresis and high performance liquid chromatography (HPLC). Beta 
thalassaemia major can be diagnosed by the complete absence of Haemoglobin A on haemoglobin 
electrophoresis, provided the test is performed before transfusion of the patient. Beta thalassaemia 
trait usually shows an elevated HbA2 level above 3.5% (normal ranges will vary from lab to lab), care 
should be taken in the presence of iron deficiency as this may reduce the HbA2 level back into the 
normal range- results should be repeated after iron replacement in any iron deficient individual. 
Alpha thalassaemia major is usually diagnosed antenatally or at the time of birth of a severely 
hydropic infant since all the normal haemoglobins present at birth contain α-chains. Three α gene 
deletions, so called HbH disease can be diagnosed by electrophoretic detection of Haemoglobin H (β4 
tetramers) or by staining a blood film with brilliant cresyl blue- the β4 tetramers in the red cells are 
stained dark blue and produce a golf-ball like appearance. The diagnosis of alpha thalassaemia trait 
(one or two gene deletions) is suspected by the presence of hypochromia and microcytosis in the 
absence of iron deficiency and with a normal HbA2 measurement. As it does not produce clinically 
significant disease, definitive diagnostic investigations (genetic testing for individual mutations) are 
usually reserved for antenatal patients at significant risk of alpha thalassaemia major in their offspring. 
Diagnostic investigations for thalassaemia are summarised in Table 28.3. 
Macrocytic Anaemia 
The cause of a macrocytic anaemia in children is often obvious from the history. History of concurrent 
or past illnesses, symptoms and signs of malabsorption, and a detailed drug history are important. B12 
and folate, liver function tests, a reticulocyte count and thyroid function should be measured in 
unexplained cases. Causes are listed in Table 28.2. 
Normocytic Anaemia 
As mentioned above a reticulocyte count is particularly useful in distinguishing reduced marrow 
production from increased destruction of red cells. The blood film can also give clues as to the most 
likely cause and best initial tests. A simple algorithm is given in Fig. 28.4. 
 Haemolytic anaemias are a large subgroup of normocytic anaemias. The combination of jaundice 
(unconjugated hyperbilrubinaemia), reticulocytosis and anaemia suggests a haemolytic process. 
Further tests for haemolysis include serum haptoglobin measurement (proteins present in normal 
plasma which can bind free haemoglobin and are then removed from the circulation by the 
reticuloendothelial system), urinary haemosiderin (an iron storage protein derived from the 
breakdown of free haemoglobin in the renal tubular system) and urobilinogen (a natural breakdown 
product of bilirubin excreted in the urine). These are summarised in Table 28.4. A key test in 
establishing the cause of haemolysis is the direct Coombs test (DCT), also called the direct antiglobulin 
test (DAT). This tests for the presence of antibody bound to the red cell surface by the use of reagents 
containing anti-IgG and anti-complement that cause agglutination of the cells as shown in Fig. 28.6. A 
positive DCT indicates a likely immune cause for the anaemia. If the DCT is negative then tests for red 
cell enzyme defects (G6PD and pyruvate kinase assays), haemoglobinopathies (haemoglobin 
electrophoresis and sickle solubility test) and membrane disorders (demonstration of increased 
osmotic fragility of cells, protein analysis by SDS-Polyacrylamide gel electrophoresis or more recent 
dye binding tests) may need to be performed. 
 If the reticulocyte count is normal or low it is likely that the anaemia is due to a problem with red 
cell production in the marrow. A bone marrow aspirate and trephine (see section on white cell 
disorders below) may be needed to help establish the cause. Lack of red cell precursors in the marrow 
can be seen as an isolated phenomenon in transient erythroblastopenia of childhood (TEC) or inherited 
red cell aplasia (Diamond-Blackfan anaemia). If part of a pancytopenia, then aplastic anaemia or 
hypoplastic myelodysplastic syndrome may be the cause. Occasionally acute leukaemias can present 
with an aplastic phase followed several weeks to months later by the development of ALL.  
Investigation of Anaemia in Neonates 
Anaemia is the commonest haematological abnormality seen in neonates. The spectrum and causes of 
disease are somewhat different than in older children. There are key differences in red cell physiology 
in neonates that contribute to the different modes of presentation in this age group. Although the 
haemoglobin tends to be high initially (due at least in part to haemoconcentration and placental 
transfusion prior to cord clamping), erythro-poiesis is then switched off at the time of birth and 
haemoglobin falls to a nadir of around 10 g/dl by the age of 8 weeks. This fall is exaggerated in 
premature infants – so called anaemia of prematurity. In addition premature babies are particularly 
vulnerable to iatrogenic anaemia secondary to blood loss associated with frequent blood testing. The 
MCV is high in neonates and differences in red cell membrane composition can make some haemolytic 
red cell disorders such as hereditary pyropoikilocytosis and hereditary spherocytosis worse in the 
neonatal period. In contrast, the enzymopathy glucose-6-phosphate dehydrogenase deficiency (G6PD) 
is not usually associated with significant haemolysis in the newborn period (unless the baby is 
exposed to oxidant stress) but may present with severe jaundice which is thought to be haepatic in 
origin. Haemolysis may also be antibody mediated due to Rhesus or ABO incompatibility between 
mother and infant. Increased red cell destruction puts the baby at risk of kernicterus caused by high 
bilirubin levels. Hence it is important to be aware of the possibility of haemolysis in all newborn 
babies.  
 Anaemia presenting soon after birth may also be due to haemorrhage pre, during or post delivery. 
Feto-maternal haemorrhage can be diagnosed by performing a Kliehauer test on the mother – this test 
looks for the presence of fetal haemoglobin containing cells in the maternal circulation by virtue of 
their ability to resist acid elution of haemoglobin. In multiple pregnancies that share a placental 
circulation twin-to-twin transfusion may also occur, producing one polycythaemic twin and one 
anaemic one. An algorithm for the diagnosis of neonatal anaemia is given in Fig. 28.5. 
Key Learning Point 
The causes and presentation of anaemia are different in neonates due to differences in red cell physiology. It is 
important to diagnose haemolytic disorders early to reduce the risk of kernicterus  
Polycythaemia 
High haemoglobins and haematocrits can be due to increased numbers of red cells (true 
polycythaemia) or dehydration leading to a decreased plasma volume (relative polycythaemia). In 
children true polycythaemia is usually due to a secondary cause such as hypoxia from cyanotic 
congenital heart disease leading to increased erythropoietin production. Occasionally kidney tumours 
can secrete erythropoietin. Primary erythrocytosis  
(a myeloproliferative disease relatively common in adults) is extremely rare in children. Neonates 
have higher incidences of polycythaemia usually secondary to placental insufficiency or delayed 
clamping of the cord. The blood viscosity increases exponentially with haematocrits above 0.65 
therefore these infants are often treated with exchange transfusion – the evidence for benefit from this 
is lacking. 
White Cell Disorders 
The white cells in the blood can be subdivided into different subpopulations with distinct functions. 
These are listed in Table 28.5 along with the main causes of high or low counts for these cells.  
Low White Cell Counts (Leucopenia) 
The commonest and most important white cell deficiency is that involving neutrophils (neutropenia) 
since this can be associated with an increased risk of serious infection. It can be caused by a defect in 
bone marrow production either affecting this cell type alone (isolated neutropenia), or as part of a 
general failure of the bone marrow to produce mature blood cells (pancytopenia). Alternatively 
neutropenia can result from peripheral destruction of neutrophils by antibodies or their redistribution 
to the tissues or sites of injury. Normal ranges for neutrophils vary between ethnic groups and are 
particularly low in black Africans. This is thought to represent a different distribution of neutrophils 
between the tissues and the circulation, rather than an overall lower total body count. Neutrophil 
numbers circulating in the bloodstream rise after exercise and as a stress response. 
 Lymphopenia can follow acute infections or periods of immunosuppression. Lymphocyte counts 
are generally higher in neonates. In neonates with lymphopenia and serious infections the possibility 
of an inherited immunodeficiency should be borne in mind. 
High White Cell Counts (Leucocytosis) 
A high neutrophil count often accompanies infection (neutrophilia) and can be a useful marker of 
sepsis. Very high neutrophil counts with evidence of immature precursors in the bloodstream are 
sometimes called a leukaemoid reaction. This can be seen with overwhelming sepsis, marrow 
infiltration by a solid malignancy, a severe stress response such as status epilepticus or burns. 
Leukaemia itself can present with high or low white cell numbers and is usually suspected by the 
combination of an abnormal blood count (white cells high or low, usually with accompanying anaemia 
and thrombocytopenia) with a blood film that shows a population of immature precursors (blast cells). 
Blast cells vary in appearance with the different subtypes of leukaemia but are generally larger than 
normal cells with a large nuclei and open chromatin (see chapter 15, Figs 15.15 and 15.16). Myeloid 
blast cells may have rod-like inclusions in their cytoplasm called Auer rods.  
 The definitive diagnosis of leukaemia usually requires bone marrow examination, this allows 
detailed study of the appearance of the red cells (morphology) as well as analysis of various specific 
proteins expressed by the cells (immunophenotyping) and genetic abnormalities (molecular genetics 
and cytogenetics) which help classify the leukaemia further and guide treatment. 
Bone Marrow Examination 
Bone marrow examination is performed for further assessment of haematological disorders where 
production of cells from the bone marrow is thought to be abnormal. In children it is often performed 
under general anaesthesia although local anaesthetic can be used if appropriate. The usual site for 
aspiration is the posterior iliac crest. A large bore needle is used to penetrate the bony cortex and enter 
the marrow cavity. Bone marrow is then aspirated and spread on glass slides, preferably immediately. 
If a good specimen is obtained then a granular appearance should be seen (see Fig 28.7). Further 
samples can be taken in appropriate anticoagulant or medium for cytogenetics, immunophenotyping 
and molecular genetic tests. In many cases a bone marrow trephine can also be taken – this involves 
introducing a longer needle below the cortex and taking a core of tissue that can then be fixed in 
formalin and sectioned for pathological examination. 
Platelet Disorders 
Platelets are small cytoplasmic fragments produced from megakaryocytes in the bone marrow and are 
important for the initiation of haemostasis and may have as yet poorly understood roles in 
inflammation. As with white and red cells, platelet disorders can be subdivided on the basis of high 
and low numbers. 
High Platelet Counts (Thrombocytosis) 
High platelet counts are usually reactive i.e. not primary bone marrow disorders but secondary to iron 
deficiency, ongoing inflammatory processes or infection. Very high platelet counts (>1500 × 109/l) can 
be associated with an increased risk of thrombosis. Primary thrombocytosis (essential 
thrombocythaemia) is rare in children. 
Low Platelet Counts (thrombocytopenia) 
Again these can be classified according to the underlying problem ie inadequate bone marrow 
production or peripheral destruction/consumption (see Table 15.3 chapter 15). Unexpectedly low 
platelet counts should always be confirmed by examination of a blood film as artefactually low 
platelet counts are not uncommon either due to partial clotting of the sample or platelet clumping, the 
latter is often an in vitro phenomenon due to EDTA dependent antibodies. The commonest cause of 
true thrombocytopenia in children is immune mediated peripheral destruction – idiopathic 
thrombocytopenic purpura (ITP). Unfortunately there is no diagnostic test for this condition so it 
remains a diagnosis of exclusion. It is characterised by the sudden onset of bruising and/or bleeding 
in an otherwise well child, often with a history of an antecedent viral infection or more rarely post 
immunisation. There should be no other abnormalities in the blood count and no lymphadenopathy or 
organo-megaly on examination. In these cases careful examination of a peripheral blood film is 
sufficient but in the presence of any abnormal or suspicious features a bone marrow examination 
should be performed to exclude leukaemia. The bone marrow in ITP shows increased numbers of 
normal megakaryocytes (as shown in chapter 15 Fig. 15.11). Although the disease is immune mediated 
platelet associated antibodies show high false positive and negative results and are therefore not 
useful in making or excluding the diagnosis. 
 Platelets may also be consumed in the periphery and a low platelet count almost always 
accompanies established disseminated intravascular coagulation (see Table 28.6). Giant 
haemangiomas (Kasabach–Merritt syndrome) or splenomegaly may also sequester and destroy 
platelets. 
 Lack of marrow production of platelets often accompanies marrow infiltration by diseases such as 
leukaemia. Other bone marrow failure syndromes such as Fanconi’s anaemia can also present initially 
with low platelets. 
 It is also possible to have a platelet function disorder. The commonest of these are Glanzmann’s 
thrombae-sthenia, usually associated with a normal platelet count, and Bernard-Soulier syndrome, 
associated with a moderate to severe thrombocytopenia. Both are due to different platelet glycoprotein 
defects and can be diagnosed by platelet function testing and flow cytometry. 
 In neonates causes of thrombocytopenia vary depending on the gestation and clinical condition of 
the baby. In well term neonates alloimmune thrombocytopenia due to the transplacental passage of 
maternal anti-platelet antibodies directed against foreign paternal antigens on the babies platelets 
(akin to the red cell disorder Rhesus haemolytic disease of the newborn) needs to be excluded. In 
preterm neonates benign gestational thrombocytopenia may be seen soon after birth but later 
appearance of thrombocytopenia often heralds sepsis.  
Coagulation Testing in Infants and Children 
Interpreting the results of coagulation screening requires some basic knowledge of the coagulation 
cascade. Coagulation tests are performed in the laboratory (in vitro) and do not faithfully replicate the 
circumstances seen in the body (in vivo). The interpretation of laboratory tests often places a lot of 
emphasis on extrinsic and intrinsic pathways but these sequences of activation probably do not play a 
major role in the initiation of clotting in vivo. Despite this the concept of extrinsic and intrinsic 
pathways is useful to be aware of when faced with an abnormal coagulation screen and is shown in 
Fig. 15.12. 
 It is now thought that the key initiating event in vivo is exposure of tissue factor in response to 
endothelial damage. Tissue factor activates factor VII to form a complex, TF-VIIa, which cleaves factor 
X to its active form Xa. Xa can convert prothrombin to thrombin with low efficiency but this 
generation of small amounts of thrombin then activates feedback loops to increase coagulation factor 
activation. Factor VIII (activated by thrombin) and factor IX (activated by TF-VIIa and factor XI) form a 
complex VIIIa-IXa known as tenase. Tenase generates activated factor X with great efficiency. 
Thrombin also activates factor V and a Xa-Va complex is formed which cleaves prothrombin to form 
thrombin. Thrombin generation leads to conversion of fibrinogen to fibrin with subsequent 
crosslinking by factor XIII. This pathway is summarized in Table 28.6. 
When to perform a coagulation screen 
 Coagulation screens should not be a routine blood test. They should be performed in any child 
with unusually severe or unexplained bleeding or in very unwell children with suspected 
disseminated intravascular coagulation. They can also be performed prior to high-risk invasive 
interventions. A good bleeding history needs to be taken to determine the need for investigation and 
to help guide appropriate tests. This includes a history of abnormal bleeding in the patient or relatives 
in response to haemostatic challenges such as tooth extraction, cuts and minor operations as well as a 
history of maenorrhagia in older females. Some clinically significant bleeding disorders can have a 
normal coagulation screen (in particular some von Willebrand’s disease and Factor XIII deficiency see 
Table 28.7) and some abnormal coagulation screens do not lead to a clinical risk of bleeding (e.g. 
Factor XII deficiency or lupus anticoagulant). Therefore the results of testing always need to be 
interpreted in the light of a clinical history.  
Key Learning Point 
Do not rely on coagulation screening as the sole indicator of bleeding risk. History of bleeding in response to a 
haemostatic challenge is just as important 
 
Coagulation Tests 
When performing a clotting screen care should be taken during venepuncture to avoid activation of 
clotting as this can produce artefactually low results. Samples should be from a free flowing vein, in 
particular heel prick samples are unsuitable in neonates. Care should be taken to avoid contamination 
with heparin – a particular problem when sampling is from an indwelling venous catheter. Like the 
FBC it is very important to be aware of normal ranges for the clotting screen especially in neonates 
who tend to have significantly prolonged values compared to older children. In addition values vary 
considerably between different automated analysers and may therefore vary between hospitals, local 
normal ranges should always be used.  
Initial screening tests should comprise: 
1. Prothrombin time (PT) –this is a test of the overall activity of the extrinsic pathway. It measures the 
activity of factors II, V, VII and X and is also dependent on adequate fibrinogen levels. 
2. Activated partial thromboplastin time (APTT) – this is a test for the overall activity of the intrinsic 
pathway and measures factors II, V, VIII, IX, X, XI and XII, it also requires adequate fibrinogen 
levels. 
3. Thrombin time (TT) – prolonged by quantitative and qualitative disorders of fibrinogen, the 
presence of inhibitory factors such as fibrin/FDPs and the presence of heparin. 
4. Fibrinogen level. 
5. Platelet count. 
 Results of these tests along with clinical history can guide subsequent investigation. Bleeding times 
are generally unhelpful. A diagnostic algorithm is shown in Table 28.8. 
 The typical findings in disseminated intravascular coagulation are shown in Fig. 28.6, although 
coagulation screening is useful in this disorder the primary therapy for DIC is treatment of the 
underlying cause. Replacement of coagulation factors with fresh frozen plasma or cryoprecipitate 
should be guided by the patient’s clinical condition and presence of other risk factors for bleeding 
rather than treating the abnormal clotting screen per se.  
Factor Assays 
Clinical aspects of inherited coagulation disorders are discussed in chapter 15. Inherited factor 
deficiencies may initially be suspected on the coagulation screen and confirmed by direct assay of the 
clotting factor. In the case of suspected von Willebrand’s disease, von Willebrand Factor (vWF) should 
be measured both quantitatively (vWF antigen) and qualitatively (a functional test such as a ristocetin 
cofactor assay). This is because low levels of vWF or normal levels of dysfunctional vWF can cause the 
disease. vWF can also rise with stress and therefore repeated testing may be needed to exclude disease 
especially in young children who are difficult to venepuncture.  
Platelet Function Testing 
Besides a platelet count and assessment of platelet morphology by light microscopy it is possible to 
assess platelet function in a number of ways. Historically a bleeding time has been used as a global test 
of platelet function but it is difficult to standardize and not very predictive of bleeding risk. Currently 
the three commonest techniques in use are platelet aggregation studies (looking at aggregation in 
response to various stimulants such as epinephrine), flow cytometry (to assess expression of 
glycoproteins on the platelet surface) and use of a platelet function analyzer (PFA-100, an automated 
machine that measures the ability of platelets to form a plug under shear stress).  
Heparin 
The presence of contaminating heparin in a sample is often initially suspected by the combination of a 
prolonged APTT with a significantly prolonged thrombin time (this test is exquisitely sensitive to 
heparin). A number of methods exist to try and confirm whether the abnormal result is due to heparin 
or not. These include a reptilase time (which measures the same pathway as the TT but is unaffected 
by heparin) or methods to neutralize the heparin using protamine sulphate. 
Monitoring of Anticoagulant Therapy 
Therapeutic anticoagulation in children is used to prevent or treat thrombosis. Heparin and warfarin 
are the two main agents in use. Heparin comes in two main formulations – standard unfractionated 
heparin and low-molecular weight heparin. The former is monitored by the APTT with a therapeutic 
range of 1.5-2.5 times normal control values. Low molecular weight heparin therapy does not prolong 
the APTT and needs to be monitored by anti-Xa levels. Warfarin therapy prolongs the PT but in order 
to standardize results between laboratories this level is converted into an international normalized 
ratio (INR), the target INR varies depending on the indication for anticoagulation.  
 
 
Table 28.1: Normal ranges for the FBC in infancy and childhood 
Haemo-    Neutro- Lympho- Mono- Eosino- Baso-  
globin  MCV WBC phils cytes cytes phils phils Platelets 
(g/dl) Hct (fl) (x109/l) (x109/l) (x109/l) (x109/l) (x109/l) (x109/l) (x109/l) 
14.9-23.7 0.47-075 100-128 10-26 2.7-14.4 2.0-7.3 0-1.9 0-0.85 0-0.1 150-450 
13.4-19.8 0.41-0.65 88-110 6-21 1.5-5.4 2.8-9.1 0.1-1.7 0-0.85 0-0.1 170-500 
9.4-13.0 0.28-0.42 84-98 5-15 0.7-4.8 3.3-10.3 0.4-1.2 0.05-0.9 0.02-
0.13 210-650 
10.0-13.0 0.3-0.38 73-84 6-17 1-6 3.3-11.5 0.2-1.3 0.1-1.1 0.02-0.2 210-560 
10.1-13.0 0.3-0.38 70-82 6-16 1-8 3.4-10.5 0.2-0.9 0.05-0.9 0.02-
0.13 200-550 
11.0-13.8 0.32-0.4 72-87 6-17 1.5-8.5 1.8-8.4 0.15-1.3 0.05-1.1 0.02-
0.12 210-490 
11.1-14.7 0.32-0.43 76-90 4.5-14.5 1.5-8.0 1.5-5.0 0.15-1.3 0.05-1.0 0.02-
0.12 170-450 
12.1-15.1 0.35-0.44 77-94 4.5-13 1.5-6 1.5-4.5 0.15-1.3 0.05-0.8 0.02-
0.12 180-430 
12.1-16.6 0.35-0.49 77-92        
Reproduced from Pediatric haematology. 3rd edition. Eds Arceci, Hann & Smith. Blackwell publishing August 2006 
 
Table 28.2: Causes of anaemia classified on red cell indices 
Hypochromic Normocytic Microcytic 
Iron deficiency Haemorrhage (acute) Vitamin B12/Folate    deficiency 
Thalassaemia Haemolysis-AIHA Reticulocytosis 
Sideroblastic  Haemoglobinopathy- Myelodysplasia 
anaemia sickle cell disease 
 
Chronic disease Red cell membrane  Hypothyroidism 
 defect- Hereditary  
 spherocytosis 
Lead poisoning Red cell enzyme  Drugs 
 defect –G6PD,  
 Pyruvate kinase 
 Marrow infiltration-  Liver disease 
 malignancy 
 Aplastic anaemia Scurvy 
 Transient Erythroblast- 
 openia of childhood 
 Bone marrow failure  
 syndromes 
 Anaemia of chronic disease 
   
 
Table 28.3: Investigation results in thalassaemia 
Diagnosis Genetic defect Blood film Haemoglobin 
electrophoresis 
Beta thalassaemia major 2 β gene mutations Severe hypochromic microcytic Absent HbA 
(pretransfusion), high HbF 
   anaemia, nucleated red cells,  
  target cells 
Beta thalassaemia trait 1 β gene mutation  Basophilic stippling, hypochromia Raised HbA2  >3.5% 
  and microcytosis but normal or  
  borderline low haemoglobin 
Alpha thalassaemia major 4 α gene deletions Very severe anaemia, nucleated  Absent HbA, A2 and 
HbF 
(incompatible with survival   red cells Presence of embryonic 
haemoglobin  
beyond embryonic period)    HbPortland and 
HbBart’s and HbH 
Haemoglobin H disease 3 α gene deletions Anaemia, target cells, teardrop  HbH 
  cells and fragments 
  HbH bodies on special staining  
  of film 
Alpha thalassaemia trait 1 or 2 α gene deletions Hypochromia, microcytosis 2-8% Hb Bart’s at birth 
(may be detected  
   on neonatal screening 
programmes) 
Table 28.4: Indicators of haemolysis 
Due to increased red cell  Raised  serum unconjugated  
destruction bilirubin 
 Raised urinary urobilinogen 
 Reduced plasma haptoglobins 
Due to increased red cell  Raised reticulocyte count 
production 
Due to presence of damaged  Abnormal morphology –  
red cells spherocytes, bite cells, fragments 
 Increased osmotic fragility 
Table 28.5:  White cell types and their disorders 
Cell type Function Causes of increased count Causes of 
decreased count 
Neutrophil Innate immunity, control of  Bacterial infection Infection – 
viral or fulminant  
 bacterial and fungal infection, Inflammatory disorders and tissue  bacterial 
 Role in phagocytosis of dead and  necrosis Autoimmune 
 damaged cells as part of  Severe marrow stress- haemorrhage or  Marrow 
failure 
 inflammation haemolysis Drugs 
  Steroid therapy African race 
  Myeloproliferative disorder (rare in children) 
Lymphocyte Adaptive immunity Acute infection especially viral e.g. Epstein  Acute stress 
including acute  
 Control of viral infection Barr virus (glandular fever) infection, 
burns, surgery, trauma 
  Chronic infection- TB, toxoplasmosis Steroids, 
Cushing’s syndrome 
  Acute leukaemia
 Immunodeficiency- congenital and  
   acquired 
including use of    
 immunosuppressive drugs 
Monocyte Part of reticuloendothelail system-  Chronic bacterial infections (TB) Marrow 
failure  
 macrophage precursors in transit Lymphoma Drugs 
  Juvenile myelomonocytic leukaemia  
  Associated with neutropenia 
Eosinophil Inflammatory responses Parasitic infection Marrow 
failure 
 Response to parasitic infection Allergy, atopy Cushing’s 
syndrome 
  Skin diseases Acute stress 
e.g. burns 
  Hodgkin’s disease Drugs 
Basophil Largely unknown, blood  Chicken pox As above 
 counterpart to tissue mast cell Myeloproliferative diseases 
  Hypothyroidism 
  Ulcerative colitis 
Table 28.6: Haematological finding in disseminated intravascular coagulation 
1. Prolonged APTT 
2. Prolonged PT 
3. Prolonged thrombin time 
4. Low fibrinogen 
5. Low platelet count 
6. Raised fibrin degradation products or D-Dimers 
7. Red cell fragmentation on the blood film 
 
Table 28.7 Bleeding disorders that may present with a normal coagulation screen and platelet count 
• Factor XIII deficiency 
• Glanzmann’s Thrombaesthenia / other platelet function disorders 
• von Willebrand’s disease 
• Vascular disorders 
Table 28.8 Causes of abnormal coagulation tests 
APTT PT TT Fibrinogen Platelets Possible Diagnosis 
Prolonged Normal Normal Normal Normal Factor VIII, IX. XI deficiency 
(Haemophilia A, B or C) von 
Willebrand’s disease Lupus 
Anticoagulant Factor XII/ 
Contact factor deficiency 
Prolonged Prolonged Prolonged Normal or low Normal or low Heparin 
     Liver disease 
     Fibrinogen deficiency 
     Vitamin K deficiency 
     DIC 
Prolonged Prolonged Normal Normal  Normal  Vitamin K deficiency  
     Warfarin 
     Factor II, V, VII, X deficiency 
Normal Prolonged Normal Normal Normal Warfarin therapy 
     Factor VII deficiency 
 
 
Fig. 28.1: A typical computer generated readout from an automated blood cell analyser (Sysmex XT2000i) 
 
 
Fig. 28.2: Red cell changes seen on blood films and their common causes (a) Spherocytes (b) Sickle cells (c) Bite 
cells (d) A pencil cell (e) Basophilic stippling (f) Target cells (g) Red cell fragments. Arrows point to the abnormal 
cell type 
Fig. 28.3: Stages of iron deficiency  
Fig. 28.4: Investigation and causes of normocytic anaemias 
Fig. 28.5: Investigation and causes of neonatal anaemia 
Fig. 28.6: The direct Coombs test 
Fig. 28.7: Example of bone marrow aspirate specimen spread on a slide and stained with H&E, note the granular 
appearance at the top of the smear 
Fig. 28.8: Haematological finding in disseminated intravascular coagulation: A 
revised coagulation cascade. Thick dashed arrows indicate low efficiency pathways. 
Thin dashed arrows indicate  
feedback activation loops. Boxes indicate complexes formed on phospholipid 
surfaces 
